Correction to: Will the reformed Cancer Drugs Fund address the most common types of uncertainty? An analysis of NICE cancer drug appraisals

.

Bibliographic Details
Main Authors: Liz Morrell, Sarah Wordsworth, Anna Schuh, Mark R. Middleton, Sian Rees, Richard W. Barker
Format: Article
Language:English
Published: BMC 2019-03-01
Series:BMC Health Services Research
Online Access:http://link.springer.com/article/10.1186/s12913-019-4039-8
_version_ 1828191951828025344
author Liz Morrell
Sarah Wordsworth
Anna Schuh
Mark R. Middleton
Sian Rees
Richard W. Barker
author_facet Liz Morrell
Sarah Wordsworth
Anna Schuh
Mark R. Middleton
Sian Rees
Richard W. Barker
author_sort Liz Morrell
collection DOAJ
description .
first_indexed 2024-04-12T08:47:46Z
format Article
id doaj.art-c8af85639a5d4f24a15a39059a629ed2
institution Directory Open Access Journal
issn 1472-6963
language English
last_indexed 2024-04-12T08:47:46Z
publishDate 2019-03-01
publisher BMC
record_format Article
series BMC Health Services Research
spelling doaj.art-c8af85639a5d4f24a15a39059a629ed22022-12-22T03:39:39ZengBMCBMC Health Services Research1472-69632019-03-011911110.1186/s12913-019-4039-8Correction to: Will the reformed Cancer Drugs Fund address the most common types of uncertainty? An analysis of NICE cancer drug appraisalsLiz Morrell0Sarah Wordsworth1Anna Schuh2Mark R. Middleton3Sian Rees4Richard W. Barker5Oxford-UCL Centre for the Advancement of Sustainable Medical Innovation, Radcliffe Department of Medicine, University of OxfordHealth Economics Research Centre, Nuffield Department of Population Health, University of OxfordDepartment of Oncology, University of OxfordDepartment of Oncology, University of OxfordHealth Experiences Institute, Nuffield Department of Primary Care Health Sciences, University of OxfordOxford-UCL Centre for the Advancement of Sustainable Medical Innovation, Radcliffe Department of Medicine, University of Oxford.http://link.springer.com/article/10.1186/s12913-019-4039-8
spellingShingle Liz Morrell
Sarah Wordsworth
Anna Schuh
Mark R. Middleton
Sian Rees
Richard W. Barker
Correction to: Will the reformed Cancer Drugs Fund address the most common types of uncertainty? An analysis of NICE cancer drug appraisals
BMC Health Services Research
title Correction to: Will the reformed Cancer Drugs Fund address the most common types of uncertainty? An analysis of NICE cancer drug appraisals
title_full Correction to: Will the reformed Cancer Drugs Fund address the most common types of uncertainty? An analysis of NICE cancer drug appraisals
title_fullStr Correction to: Will the reformed Cancer Drugs Fund address the most common types of uncertainty? An analysis of NICE cancer drug appraisals
title_full_unstemmed Correction to: Will the reformed Cancer Drugs Fund address the most common types of uncertainty? An analysis of NICE cancer drug appraisals
title_short Correction to: Will the reformed Cancer Drugs Fund address the most common types of uncertainty? An analysis of NICE cancer drug appraisals
title_sort correction to will the reformed cancer drugs fund address the most common types of uncertainty an analysis of nice cancer drug appraisals
url http://link.springer.com/article/10.1186/s12913-019-4039-8
work_keys_str_mv AT lizmorrell correctiontowillthereformedcancerdrugsfundaddressthemostcommontypesofuncertaintyananalysisofnicecancerdrugappraisals
AT sarahwordsworth correctiontowillthereformedcancerdrugsfundaddressthemostcommontypesofuncertaintyananalysisofnicecancerdrugappraisals
AT annaschuh correctiontowillthereformedcancerdrugsfundaddressthemostcommontypesofuncertaintyananalysisofnicecancerdrugappraisals
AT markrmiddleton correctiontowillthereformedcancerdrugsfundaddressthemostcommontypesofuncertaintyananalysisofnicecancerdrugappraisals
AT sianrees correctiontowillthereformedcancerdrugsfundaddressthemostcommontypesofuncertaintyananalysisofnicecancerdrugappraisals
AT richardwbarker correctiontowillthereformedcancerdrugsfundaddressthemostcommontypesofuncertaintyananalysisofnicecancerdrugappraisals